Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 1/2012

01-03-2012 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices

Authors: Keyur B. Shah, Daniel G. Tang, Richard H. Cooke, Michael C. Kontos, Neil P. Lewis, Gundars J. Katlaps, Michael L. Hess, Vigneshwar Kasirajan

Published in: Current Heart Failure Reports | Issue 1/2012

Login to get access

Abstract

The medical community has seen an explosive rise in the utilization of implantable mechanical circulatory support devices for late-stage cardiomyopathy. Care for these complex patients requires a basic understanding of device physiology and potential complications. This review focuses on an algorithm that incorporates a careful clinical history and examination with diagnostic modalities for the evaluation of a patient who is failing therapy with a continuous-flow left ventricular assist device, as well as the general management and optimization of patients implanted with an artificial heart.
Literature
1.
• Slaughter MS, Rogers JG, Milano CA, et al. The HeartMate II investigators: advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51. This randomized controlled trial established the superiority of continuous-flow LVADS over displacement-pump LVADs.PubMedCrossRef
2.
Miller LW, Pagani FD, Russell SD, et al. The HeartMate II clinical investigators: use of a continuous flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.PubMedCrossRef
3.
Copeland JG, Smith RG, Arabia FA, et al. The CardioWest total artificial heart investigators: cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859–67.PubMedCrossRef
4.
•• Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39. This is a comprehensive resource reviewing patient selection, surgical considerations, and postoperative management of patients after implantation of the HeartMate II LVAD.PubMedCrossRef
5.
Bennett MK, Roberts CA, Dordunoo D, et al. Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2010;29:593–4.PubMedCrossRef
6.
Vollkron M, Voitl P, Ta J, et al. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819–25.PubMedCrossRef
7.
Rose AG, Park SJ, Bank AJ, Miller LW. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg. 2000;70:1270–4.PubMedCrossRef
8.
Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269–74.PubMedCrossRef
9.
Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in LVAD supported patients. Circ Heart Fail. 2010;3:668–74.PubMedCrossRef
10.
Pak S, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172–6.
11.
Myers TJ, Bolmers M, Gregoric ID, et al. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423–7.PubMedCrossRef
12.
Palardy M, Nohria A, Rivero J, et al. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218–24.PubMedCrossRef
13.
Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.PubMedCrossRef
14.
Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.PubMedCrossRef
15.
Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213–9.PubMedCrossRef
16.
Horton SC, Khodaverdian R, Chatelain P, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45:1435–40.PubMedCrossRef
17.
Jaski BE, Miller DA, Hoagland PM, et al. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction. J Heart Lung Transplant. 2005;24:2060–7.PubMedCrossRef
18.
Raman SV, Sahu A, Merchant AZ, et al. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J Heart Lung Transplant. 2010;29:79–85.PubMedCrossRef
19.
Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.PubMedCrossRef
20.
Thomas MD, Wood C, Lovett M, et al. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant. 2008;27:925–7.PubMedCrossRef
21.
Delgado R, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005;24:231–3.PubMedCrossRef
22.
Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997;11(Suppl):S5–10.PubMedCrossRef
23.
Stribling W, Shah KB, Gunnerson K, et al. Use of nesiritide and renal function following total artificial heart implantation. J Heart Lung Transplant. 2011;30:S96.CrossRef
24.
Delgado R, Wadia Y, Kar B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005;24:1166–70.PubMedCrossRef
25.
El-Banayosy A, Arusoglu L, Morshuis M, et al. CardioWest total artificial heart: Bad Oeynhausen experience. Ann Thorac Surg. 2005;80:548–52.PubMedCrossRef
26.
Ensor CR, Cahoon WD, Crouch MA, et al. Antithrombotic therapy for the CardioWest temporary total artificial heart. Tex Heart Inst J. 2010;37:149–58.PubMed
Metadata
Title
Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices
Authors
Keyur B. Shah
Daniel G. Tang
Richard H. Cooke
Michael C. Kontos
Neil P. Lewis
Gundars J. Katlaps
Michael L. Hess
Vigneshwar Kasirajan
Publication date
01-03-2012
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 1/2012
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-011-0079-z

Other articles of this Issue 1/2012

Current Heart Failure Reports 1/2012 Go to the issue

Pharmacologic Therapy (WHW Tang, Section Editor)

Should We Start Prescribing Omega-3 Polyunsaturated Fatty Acids in Chronic Heart Failure?

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK HASAN, Section Editor)

Resistance Versus Aerobic Exercise Training in Chronic Heart Failure

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

The Emerging Role of Cardiac Resynchronization Therapy in Milder Heart Failure: Are We Implanting Too Late for Response?

Pharmacologic Therapy (W. H. Wilson Tang, Section Editor)

Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Surgical Approach to Mitral Regurgitation in Chronic Heart Failure: When Is It an Option?

Pharmacologic Therapy (W. H. Wilson Tang, Section Editor)

Pharmacologic Strategies to Target Oxidative Stress in Heart Failure
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits